Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

A report from the human resources trade group SHRM, which just released its 2025 Benefits Survey—the most comprehensive ...

I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.' ...

Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.